ArticleMethods in molecular biology (Clifton, N.J.)2025
Characterization of Bone Marrow-Derived Immune Compartment in Murine Brain Metastases by Spectral Flow Cytometry.
Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Metastatic brain cancer is the most common intracranial cancer among adults, often leading to poor survival outcomes. The incidence of brain metastases is on the rise, likely associated with advanced systemic therapeutics which improve patient survival, providing sufficient time for micrometastases to develop into fully established metastases. Therefore, brain metastasis remains an unmet clinical need. The brain metastatic tumor microenvironment is a complex ecosystem composed of numerous brain, stromal, and immune cells with unique adaptations that represent a formidable challenge for treatment. Importantly, brain metastases are enriched in immune cells, especially myeloid resident and recruited cells considered highly plastic. Thus, it is critical to assess the immune landscape and functional phenotypes longitudinally and across treatment conditions in brain metastasis in a non-biased, comprehensive manner. Here, we outline a protocol to assess immune cell populations in murine brain metastasis samples, using a 23-color panel for spectral flow cytometry.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.